NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that it will host a research and development day for the investment community on Monday, January 23, 2012 at 8:30 am Eastern Time. The event will provide updates on the Company’s robust pipeline in oncology and cancer immunotherapy, featuring presentations from leading researchers and investigators as well as Celldex management. For information on attending the event, please contact Sarah Cavanaugh at scavanaugh@macbiocom.com.
